The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer
Eva Pastille(University of Duisburg-Essen), Philippe Krebs(University of Bern)
Cited by 144
Related Papers
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
|Journal of Clinical Investigation|2015|90